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Abstract 
 
This retrospective study is aimed at evaluating the role of CT scan in predicting parametrium involvement in early 
stage of cervical carcinoma. It was conducted in a Gynaecologic Oncology Centre, Hospital Alor Star from January 
2004 till December 2008. All patients with operable stage I and II cervical cancer had pelvic CT scan for evaluation 
of parametrium involvement before undergoing radical hysterectomy and pelvic lymphadenectomy. Parametrial 
streakiness or presence of infiltration suggested local invasion. Following radical hysterectomy, the specimens sent 
for histological confirmation and the correlation between the CT scan finding and the histopathology result was 
studied. The result revealed a total of 104 patients with operable stage cervical carcinoma had pelvic CT scan. The 
sensitivity and the specificity of CT scan in assessing parametrial involvement was 33.3% and 84.8%, respectively. 
In conclusion, CT scan had high specificity but low sensitivity in determining parametrial involvement in early stage 
of cervical cancer. Hence, routine preoperative pelvic CT scan has a limited role in assessing parametrial 
involvement in early stage cervical carcinoma. 
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Introduction 
 
Invasive cervical carcinoma is the commonest female 
genital malignancy and has implicated a great 
socioeconomic burden universally. The estimated 
number of new cases is 371,200 per year worldwide 
or 9.8% of all cancers in women (1, 2). Invasive 
cervical cancinoma still remains imperative cause of 
cancer morbidity and ultimately lead to mortality 
although most of reports indicate a significant decline 
in its incidence (2). Advancement in Human 
Papilloma Virus (HPV) vaccination programme is 
most likely responsible for this favourable trend.   
 
Direct spread is the main mode of invasion in cervical 
cancer consisting microscopic infiltration to the vaginal 
mucosa, uterus, parametrium and pelvic side walls. In 
more advanced stage, extension to the regional pelvic 
lymph nodes and retroperitoneal nodes are expected in 
vast majority of cases. Both direct extension and 
lymphatic invasion affecting tissues laterally later 
intrudes into cardinal ligaments and pubovesical-
cervical fascia.  Tumor infiltration to the lateral 
parametrium is more common than anterior or posterior 
parametrium as the covering fascia in this region is 
deficient.   It is also due to natural lymphatic drainage 
to the cardinal ligaments via lateral paracervical tissues.  
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Staging of the cervical carcinoma is the utmost 
important aspect for the determination of prognosis and 
plan of further management. The International 
Federation of Gynecology and Obstetrics (FIGO) 
believed that any staging system should be universally 
feasible and applicable and it should provide a 
worldwide standardized classification that allowed 
various medical centres to compare results (3,4).  
 
Consensus from FIGO clearly indicate that clinical 
staging which performed pre-treatment would be 
entirely reliable tool to stage the cervical carcinoma. 
This includes pelvic examination to evaluate 
rectovaginal, parametrium and pelvic side wall 
involvement, cystoscopy, proctoscopy and 
intravenous urography (5). Computed Tomography 
(CT) scan and Magnetic Resonant Imaging (MRI) are 
not generally accepted as a compulsory to stage the 
disease, but can be used as an adjunct assessment tool 
prior to treatment.  It is not widely available in 
developing countries, variable techniques and 
technologies with non-standardized interpretation 
ability. This non synchronization provides 
discrepancy in cancer reporting consensus. In 
contrast, surgical-pathological staging is not feasible 
in those surgically deemed contraindicated which 
include advanced, inoperable disease, or even in early 
stage where radiotherapy may play its absolute role.  
 
There are limitations in the FIGO clinical staging 
system in term of estimation of the size of the primary 
tumor, particularly in endocervical lesion. Accurate 
determination of the size is important because it is 
significantly correlated with lymph node metastases 
and prognosis is very much dependent on the volume 
of the primary tumour (5,6). Other limitations include 
evaluation of tumor extension into the parametrium 
and pelvic sidewalls, presence of lymphadenopathy 
and distant metastasis. Hence, concerns rise on 
utilizing CT and/ or MRI imaging as assessment tools 
combining with traditional clinical staging in cervical 
carcinoma. It is shown to be more reliable compared 
to clinical pelvic assessment alone in evaluating local 
tumour spread to the parametrium, pelvic side wall 
and even retroperitoneal lymph nodes (6).  
 
This study was aimed at determining the role of 
pelvic CT scan in predicting parametrial involvement 
in the early stage of cervical carcinoma. Further, the 
correlation between CT scan findings and 
histopathology results was determined.   
 
Materials and Methods 
 
This retrospective study was evaluating all cases of 
operable stage cervical cancer over the period of five 
years from January 2004 till December 2008. The 
sample population consisted all patients with operable 
stage of cervical carcinoma (11A and below), whom 
underwent radical hysterectomy during the study 
period in Gynaecologic Oncology Centre, Hospital 
Alor Star. Exclusion criteria involved inoperable 
cases which were found intraoperatively, when 
radical hysterectomy was abandoned. 
 
All patients with cervical carcinoma were staged 
based on universally accepted FIGO staging. The 
study group had a CT scan of the pelvis performed 
prior to the radical hysterectomy. The CT scan was 
performed for the purpose of obtaining additional 
information and not for staging purposes. Single slice 
spiral scanner with oral and intravenous contrast was 
used as a standard procedure and the findings were 
reported by the same team of radiologists. Parametrial 
involvement was reported as irregularity or nodularity 
of the cervical contours, increased attenuation and 
prominent or thick soft-tissue strands in the 
parametrial  and/or periureteral fat, confluent soft 
tissue that replaces the periureteral fat or eccentric 3-
dimensional parametrial soft-tissue mass. 
 
The radical hysterectomy was performed by a trained 
Gynaecology team with adequate facilities. 
Specimens removed during the radical hysterectomy 
were sent for histopathological examination where the 
presence of parametrial involvement was confirmed. 
The correlation between the radiological and the 
histological findings was analyzed. 
 
Results  
 
A total of 140 patients underwent radical 
hysterectomy during the period of this study.  Of 
these, 104 patients had CT scan assessment prior to 
the surgery for the parametrial evaluation. Majority of 
the patients were Malays which contributed to the 
highest percentage of 57.1%, followed by Chinese 
and Indian (Table 1). 
 
The classification of clinical stage was based on 
standardized FIGO staging criteria. Majority of 
patients were stage 1B1, comprised of 57.7%. The 
distribution of the study population who had radical 
hysterectomy was categorized according to the stage 
of disease as shown in Table 2. 
 
From the statistical calculation, we found that the 
sensitivity of CT scan in detecting parametrial 
involvement was 33.3% but it had higher specificity 
of 84.8%. It showed CT scan had poor detection rate 
in early stage of parametrial involvement but a 
negative test could exclude the disease better. The  
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Table 1: Ethnicity of the study population 
Race/  Number Case Percentage (%) 
Malay 60 57.1 
Chinese 32 31.4 
Indian 8 8.6 
Others 4 2.9 
Total 104 100.0 
 
Table 2: FIGO Clinical Staging 
Clinical stage No. of patient 
1A2 4 (2.9%) 
1B1 60 (57.7%) 
1B2 28 (26.9%) 
2A 12 (11.5%) 
Total 104 (100%) 
 
Table 3: Correlation between CT scan finding and 
Histopathological confirmation 
CT Scan 
Hpe 
Positive Negative Total 
Positive 4 14 18 
Negative 8 78 86 
Total 12 92 104 
 
positive predictive and negative predictive values 
were 22.2% and 90.7% respectively (Table 3). 
 
Discussion 
 
Previous data revealed that CT evaluation of 
parametrial invasion had overall accuracy of 76%, a 
positive predictive value of 58%, and a negative 
predictive value of 85% (7). However, in our study 
we found the same trend of results with lower positive 
predictive value of 22.2% but the negative predictive 
value was almost the same, 90.7%. Most probably, 
the longer study period with higher number of cases 
should be recruited and interpretation of CT scan by 
different radiologist might affect the findings of the 
CT scan.  
 
In the assessment of parametrial tumour invasion, the 
reported false positive rate of CT scan was in the 
range of 35% to 70%. It was also implicated to the 
‘under staging’ of the disease in 12% to 33% of 
patients with clinical stage IIb and IIIb, due to 
inability of CT scan in detecting microscopic tumor 
invasion in the parametrial region (8). However, the 
accuracy of CT scan prediction is increased in the 
advanced stage, being as high as 92% in evaluating 
patients with stage IIIb to IVb disease (7).   
However, there are pitfalls and limitations of CT scan 
in the assessment of parametrium in the cervical 
cancer. Normal parametrial vessels and/or uterine 
ligaments could be misinterpretated as evidence of 
parametrial tumor invasion. Parametritis secondary to 
surgical biopsy, cervical conisation, uterine curettage, 
or infection of the primary tumour have similar 
appearances of the irregular cervical margins and 
adjacent soft-tissue stranding due to parametrial 
tumor invasion. Therefore, adequate clinical 
information to the attending or reporting radiologist is 
the utmost important for accurate correlation of the 
radiological findings. 
In general, 
the accuracy of CT in the overall staging of cervical 
cancer was reported as 58-88% (7,8), which 
consistent to our findings of 84.8%. 
 
Previous studies found CT scan is more reliable for the 
assessment in patients with advanced disease invading 
beyond uterus- namely stage IIb and beyond, 
evaluating lymph nodes enlargement and guided 
biopsy, and delineating the urinary systems (9). 
 
Alas, CT scan has limited reliability in determining 
tumour size and detecting early tunour invasion to the  
parametrium which shown in our study, and further 
supported by previous studies (7,8,9). 
 
Concensus by FIGO clearly stated that, clinical 
staging by an experienced Gynaecologic Oncologist is 
more accurate than CT scan in evaluating patients 
with stage Ib or IIa tumours. This statement is further 
supported by the 
 
The Royal College of Obstetricians 
and Gynaecologists, UK (RCOG) guideline which not 
favouring routine CT scan in staging early cervical 
cancer. In this study, bias for the clinical staging is 
minimized by designating a trained Gynaecologist or 
a supervised gynae-oncology trainee to perform the 
evaluation.  
We conclude that, CT scan has high specificity and 
low sensitivity value in predicting the parametrial 
involvement of early stage of cervical cancer. On the 
other hand, MRI may have an exceptional soft-tissue 
contrast resolution, which may exceed CT and 
ultrasonography (US). Therefore, MRI is significantly 
more  important than CT scan and US in the  
evaluation of the  tumour size, the depth of cervical 
invasion, and the local-regional extent of the disease 
(direct invasion of the parametrium, pelvic sidewall, 
bladder, or rectum) (10). CT and MRI are relatively 
have comparable value and more excellent than US, 
in evaluating enlarged lymph nodes thus, play more 
accurate staging modalities than ultrasound scan (10).  
Although MRI shown to be superior to CT scan, but 
most literatures still recommend later imaging 
technique for evaluation pretreatment cervical 
carcinoma. This attributed to insignificant effect of 
MRI findings to the clinical decision-making or on 
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the choice of therapy (11,12). In general, CT scan and 
perhaps MRI are not warranted in patients with small-
volume early disease (stage Ib disease and cervical 
tumor diameter <2.0 cm) because of the low 
probability of parametrial invasion and nodal 
metastasis. Imaging with CT or MRI is appropriate 
when the cervical tumor is larger than 2.0 cm, when 
the size of the tumor cannot be adequately evaluated 
during clinical examination, or when the tumor is 
endocervical (11,12). 
 
Conclusion 
 
We found that CT scan had low sensitivity and 
positive predictive values but had high specificity in 
excluding tumour invasion in early stage cervical 
cancer. Therefore, a routine CT scan assessment of 
the parametrium in the early stage of cervical cancer 
has a limited role.  
 
The clinical staging of cervical cancer by a trained 
Gynaecologist is of paramount importance and CT 
scan could be used as an adjunct investigation before 
the definitive treatment. Probably, CT scan is more 
helpful in the advanced stage, for the nodal assesment 
or detection of distant metastasis. 
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